COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Apollo

Purpose of Study

Evaluate the safety and efficacy of Medtronic Intrepid TMVR System in patients with severe symptomatic mitral regurgitation who are candidates for conventional mitral valve surgery

Trial Status

Enrolling

Eligibility Criteria

Patients that have severe symptomatic mitral regurgitation, Heart Team agress that patient is a candidate for bioprosthetic mitral valve replacement, patient will return for all required post procedure follow up visits

Duration of Participation

Approximately 5 years

Contact Name: Kendra Tuttle, RN

Contact Phone: 515-235-5102

Contact Email: ktuttle@iowaheart.com